Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioReliance Corp.

Division of Merck KGAA
www.bioreliance.com

Latest From Acadia Pharmaceuticals Inc.

Execs On The Move, June 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical

New Active Substance Launches Declined Again In 2016

2016 witnessed a second straight year of decline in the number of new active substance launches worldwide, but trend data show that this hard measure of R&D productivity was still healthy compared with industry's performance during the first decade of the century.

Research & Development Companies

Behind The Blockbuster: Investors Sound Off On Biogen's Future With Spinraza

Entering 2017 with freshly approved Spinraza and new CEO Michel Vounatsos, Biogen still faces challenges and uncertainty. A poll of investors highlights expectations for the company.

Business Strategies Commercial

Stockwatch: Pricing Delusions Of Blockbuster Proportions

Sales expectations for the products of companies like Acadia, BTG, Keryx and probably Sarepta remain too high, despite the bursting of the last biotech bubble. Aggressive price increases have traditionally been one way to inch closer to those expectations but that door has closed.

Pricing Strategies Sales & Earnings
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • In Vitro Diagnostics
  • Pharmaceuticals
    • Nutraceuticals
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Microbiological Associates
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Merck KGAA
  • Senior Management
  • Charles Harwood, Pres. & CEO
    David Onions, PhD, CSO
    David L Bellitt, VP, Global Commercial Ops., Biologics
  • Contact Info
  • BioReliance Corp.
    Phone: (301) 738-1000
    14920 Broschart Rd.
    Rockville, MD 20850-3349
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register